Philly Leader

NexGen Hyperbaric has announced a partnership with the Philadelphia Flyers, marking a significant development in player health and wellness within the National Hockey League (NHL). The Flyers are now the first NHL team to incorporate hyperbaric oxygen therapy (HBOT) into their wellness plan for both current players and alumni. This collaboration aims to enhance player longevity, performance, and recovery using NexGen's mobile hyperbaric system.

Ian McKeown, Vice President of Athlete Performance & Wellness for the Flyers, expressed enthusiasm about the partnership: "NexGen Hyperbaric is a partner that the Flyers are very excited to be working with as we look to the future of advanced care for our athletes." He emphasized that NexGen aligns with their vision of enhancing player performance and wellness through cutting-edge technology.

The decision by the Flyers sets a new standard in sports medicine by providing HBOT access not only to active players but also to former ones. This initiative acknowledges the long-term impacts of professional hockey on athletes' health. By offering this treatment, the team aims to support recovery and cognitive health beyond an athlete's active career.

Jonathan Rotella, CEO of NexGen Hyperbaric, praised this pioneering move: “By committing to the health and well-being of both current and former players, the Flyers are truly leading the way in sports medicine and recovery.” He highlighted that this effort extends care beyond immediate game recovery, ensuring lasting benefits for those who have contributed significantly to the team's legacy.

The integration of HBOT is part of a broader strategy by the Flyers to optimize both physical and mental health. The therapy is known for accelerating injury recovery, improving cognitive function, and promoting overall wellness. This approach reflects a commitment not only to current players but also offers former athletes tools for improved quality of life post-retirement.

###